Merck KGaA
DEEURMerck KGaA (LSE:0O14) — Drug Manufacturers - Specialty & Generic. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 3. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
- Merck KGaA ADR — 1MRKX · MI US CIK 310158 · LEI 4YV9Y5M8S0BRK1RP0397 · ISIN US58933Y1055
Par uzņēmumu
- Tīmekļvietne
- merckgroup.com
- Nozare
- Healthcare · Drug Manufacturers - Specialty & Generic
- Galvenā mītne
- Darmstadt, Germany
- Izpilddirektors
- Belén Garijo
- Darbinieki
- 60 348
- Dibināts
- 1668
- Biržā kopš
- 17.07.2007 (LSE:0O14)
- Apgrozībā esošās akcijas
- 129.24 milj.
- Brīvā apgrozība
- 128.87 milj.
- Tirgus kapitalizācija
- 59.93 mljrd. EUR
- Iekšējās personas
- 0%
- Institucionālie investori
- 57.83%
Apraksts
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Dividendes
Merck KGaA (MRK) izmaksā dividendes reizi gadā. Pēdējo 12 mēnešu laikā tika samaksāts 2.2 EUR par akciju (maksājumi: 1). Tas ir aptuveni 1.59% no pašreizējās akciju cenas. Pamatojoties uz maksājumu vēsturi, nākamais ex-dividendes datums tiek gaidīts ap 26.04.2027.
| Ex-datums | Izmaksa | Summa | % | Veids | Tikeris |
|---|---|---|---|---|---|
| 2026-04-27 | 2026-04-29 | 2.2000 EUR | 1.6/1.6 % | ikgadējs | XETRA:MRK |
| 2025-04-28 | 2025-04-30 | 2.2000 EUR | 1.6/1.6 % | ikgadējs | XETRA:MRK |
| 2024-04-29 | — | 2.2000 EUR | 1.6/1.6 % | ikgadējs | XETRA:MRK |
| 2023-05-02 | — | 2.2000 EUR | 1.6/1.6 % | ikgadējs | XETRA:MRK |
| 2022-04-25 | — | 1.8500 EUR | 1.3/1.3 % | ikgadējs | XETRA:MRK |
Ziņas šonedēļ
Ziņu no uzņēmuma vietnes vēl nav.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| First Eagle Funds-First… | 4.7% | 6.07 milj. | 2026-07-31 |
| MFS Series Trust XVII-MF… | 1.78% | 2.3 milj. | 2026-06-30 |
| First Eagle Funds-First… | 1.59% | 2.06 milj. | 2026-07-31 |
| VANGUARD STAR FUNDS-Vang… | 1.48% | 1.91 milj. | 2026-07-31 |
| Bridge Builder Trust-Bri… | 1.36% | 1.76 milj. | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.98% | 1.27 milj. | 2026-06-30 |
| MFS SERIES TRUST I-MFS R… | 0.76% | 988 028 | 2026-05-31 |
| iShares Trust-iShares Co… | 0.75% | 964 996 | 2026-08-31 |
| MFS SERIES TRUST X-MFS I… | 0.73% | 947 855 | 2026-05-31 |
| BNY Mellon Strategic Fun… | 0.41% | 532 200 | 2026-05-31 |
| Generali Investments Cee… | 0% | 6 236 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 4 926 | 2026-06-30 |
| Reik & Co., Llc | 0% | 4 000 | 2026-06-30 |
| Gamma Investing LLC | 0% | 34 | 2026-09-30 |
